To drive clinical translation of cell and gene therapies worldwide.
To improve lives through safe and effective cell and gene therapies.
- Promote innovation in translational research
- Strive for excellence in everything we do
- Respect and support diversity and inclusivity
- Uphold the highest ethical standards
- Serve our members and advocate for our society
Established in 1992, the International Society for Cell & Gene Therapy (ISCT) is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective therapies to improve patients' lives worldwide.
ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.
Comprised of over 3,000 cell and gene therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders, and organizations invested in cell and gene therapy translation.
For more information about the organization, key initiatives and upcoming meetings, please visit: isctglobal.org, @ISCTglobal.